Skip to content

Clinical Data Collection of Myopic Patients After PTK-PRK With CZM MEL 90 Excimer Laser

Clinical Data Collection of Myopic Patients After PTK-PRK With CZM MEL 90 Excimer Laser for Verification of Predicted Refractive Outcome Using EpiMaster Software Considering Epithelial Remodelling

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06996353
Enrollment
150
Registered
2025-05-30
Start date
2025-05-26
Completion date
2027-06-30
Last updated
2026-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Errors

Brief summary

The objective of the clinical investigation presented to is to verify predictions of post-operative PTK-PRK refractive outcome made by the EpiMaster application software by comparing these to post-operative clinical data after routine PTK-PRK treatments.

Detailed description

The objective of the clinical investigation presented to is to verify predictions of post-operative PTK-PRK refractive outcome made by the EpiMaster application software by comparing these to post-operative clinical data after routine PTK-PRK treatments. The EpiMaster application software is not used in this clinical investigation, consequently, it is a merely observational investigation.

Interventions

PROCEDUREPTK-PRK refractive treatment

The PTK-PRK refractive treatment will be done according to routine clinical practice.

Sponsors

Optana GmbH
CollaboratorOTHER
London Vision Clinic
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Inclusion criteria are according to the user manual of CZM MEL 90 Excimer Laser for treatment of refractive errors * Patient present with myopic or myopic and astigmatic error * Patient will be able to understand the patient information and willing to sign an informed consent * Patient will be willing to comply with all follow-up visits and the respective examinations

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Difference of SE(measured) and SE(predicted by EpiMaster)6 monthsPercentage of eyes with SE6 months post-op measured - SEpredicted by EpiMaster within ±1.00D, with SE being the spherical equivalent

Countries

India

Contacts

Primary ContactTimothy Archer, PhD
timothy@londonvisionclinic.com+44 02072241005

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026